Your browser is no longer supported. Please, upgrade your browser.
Settings
JNP Juniper Pharmaceuticals, Inc. daily Stock Chart
JNP [NASD]
Juniper Pharmaceuticals, Inc.
Index- P/E9.01 EPS (ttm)0.52 Insider Own2.90% Shs Outstand11.08M Perf Week-1.06%
Market Cap51.52M Forward P/E- EPS next Y-0.34 Insider Trans0.63% Shs Float10.40M Perf Month-6.06%
Income5.90M PEG- EPS next Q-0.09 Inst Own36.50% Short Float1.17% Perf Quarter-15.45%
Sales54.60M P/S0.94 EPS this Y484.50% Inst Trans0.17% Short Ratio3.95 Perf Half Y-19.97%
Book/sh3.68 P/B1.26 EPS next Y55.80% ROA11.50% Target Price10.88 Perf Year-32.02%
Cash/sh1.90 P/C2.45 EPS next 5Y- ROE17.50% 52W Range4.30 - 8.00 Perf YTD-16.96%
Dividend- P/FCF6.78 EPS past 5Y-20.60% ROI12.30% 52W High-41.87% Beta0.34
Dividend %- Quick Ratio1.90 Sales past 5Y4.90% Gross Margin55.50% 52W Low8.14% ATR0.18
Employees139 Current Ratio2.30 Sales Q/Q143.00% Oper. Margin9.70% RSI (14)36.94 Volatility3.23% 3.73%
OptionableYes Debt/Eq0.06 EPS Q/Q- Profit Margin10.90% Rel Volume1.03 Prev Close4.65
ShortableYes LT Debt/Eq0.06 EarningsMar 07 BMO Payout0.00% Avg Volume30.77K Price4.65
Recom2.50 SMA20-4.66% SMA50-6.81% SMA200-20.31% Volume31,757 Change0.00%
Aug-19-16Downgrade H.C. Wainwright Buy → Neutral $6.75
Aug-18-16Downgrade Northland Capital Outperform → Market Perform
Mar-01-16Initiated H.C. Wainwright Buy $18
Mar-29-17 08:00AM  Juniper Pharmaceuticals Recognized for Board Diversity at Get Konnected! 9th Anniversary Event PR Newswire
Mar-20-17 09:56AM  Juniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: 2016 By the Numbers : March 20, 2017
Mar-10-17 01:04PM  JUNIPER PHARMACEUTICALS INC Financials
Mar-07-17 07:07AM  Q4 2016 Juniper Pharmaceuticals Inc Earnings Release - Before Market Open
06:14AM  Juniper Pharmaceuticals posts 4Q profit
06:12AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
06:00AM  Juniper Pharmaceuticals Reports Fourth Quarter and Full-Year 2016 Financial and Operating Results PR Newswire
Mar-06-17 01:00PM  Juniper Pharmaceuticals to Present at ROTH Conference on March 14, 2017 PR Newswire
Mar-01-17 08:45AM  Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2016 Results on March 7, 2017 PR Newswire
Feb-16-17 11:19AM  Latest version of Dodd-Frank reversal bill would exempt a third of public companies from giving auditor warning at MarketWatch
Jan-26-17 07:00PM  Juniper Pharmaceuticals Presents Poster at SMFM 2017 on Current Practice Among U.S. Obstetricians to Screen, Define, and Treat a Short Cervix to Prevent Preterm Birth PR Newswire
Jan-06-17 08:00AM  Juniper Pharmaceuticals Unveils Strategic and Product Development Objectives for 2017 PR Newswire
Jan-05-17 08:30AM  Juniper Pharmaceuticals Announces Poster Presentation at Society for Maternal-Fetal Medicine 2017 Annual Meeting PR Newswire
Dec-23-16 04:05PM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
Dec-20-16 08:00AM  Juniper Pharmaceuticals Announces Appointment of Jeffrey Young as Chief Financial Officer PR Newswire
Dec-15-16 06:23AM  Hedge Funds Are Crazy About Avinger Inc (AVGR) at Insider Monkey
Nov-29-16 10:56AM  Juniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
Nov-16-16 05:01PM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, -5.04%
Nov-15-16 07:07AM  Q3 2016 Juniper Pharmaceuticals Inc Earnings Release - Before Market Open +9.17%
06:39AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
06:07AM  Juniper Pharmaceuticals posts 3Q profit
06:00AM  Juniper Pharmaceuticals Monetizes U.S. Crinone Royalty Stream with Allergan PR Newswire
05:59AM  Juniper Pharmaceuticals Reports Third Quarter 2016 Financial Results PR Newswire
Nov-14-16 05:45PM  JUNIPER PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report -5.22%
05:09PM  JUNIPER PHARMACEUTICALS INC Files SEC form 10-K/A, Annual Report
04:01PM  Juniper Pharmaceuticals to Report Third Quarter 2016 Results on November 15, 2016 PR Newswire
Oct-28-16 01:15PM  Lifshitz & Miller Law Firm Announces Investigation of Advaxis, Inc., Banc of California, Inc., Biogen Inc., Franklin Resources, Inc., Juniper Pharmaceuticals, Inc., Opus Bank, Taro Pharmaceutical Industries Ltd., and Tyson Foods, Inc. PR Newswire
Oct-27-16 04:36PM  Harwood Feffer LLP Announces Investigation of Juniper Pharmaceuticals, Inc. PR Newswire
01:30PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Juniper Pharmaceuticals, Inc. (JNP) PR Newswire
Oct-26-16 06:55PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Juniper Pharmaceuticals, Inc. on Behalf of Shareholders Business Wire
Oct-25-16 09:59AM  JUNIPER (JNP) ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigation of Juniper Pharmaceuticals, Inc.; Encourages Long-Term Investors to Contact the Firm PR Newswire
Oct-24-16 06:03PM  Juniper Pharma to restate results since 2013
05:04PM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review
Oct-12-16 02:33PM  Rebound May Be in Store for Beaten-Down Shares of TherapeuticsMD
Sep-23-16 10:20AM  ETFs with exposure to Juniper Pharmaceuticals, Inc. : September 23, 2016
Sep-07-16 06:45PM  Weekly CFO Buys Highlights
Aug-31-16 01:00PM  Juniper Pharmaceuticals to Present at Rodman & Renshaw Global Investment Conference on September 12, 2016 PR Newswire
Aug-22-16 11:37AM  ETFs with exposure to Juniper Pharmaceuticals, Inc. : August 22, 2016
Aug-21-16 10:05AM  6 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Aug-19-16 07:05AM  Juniper Pharma downgraded by H.C. Wainwright
Aug-18-16 11:50AM  Thursdays Top Health Care Stocks Punishing Investors at 24/7 Wall St. -19.24%
06:02AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Aug-17-16 05:25PM  Juniper Pharmaceuticals Reports Results from Phase 2b Clinical Trial of COL-1077 Lidocaine Vaginal Gel in Gynecologic Procedure Pain PR Newswire
Aug-11-16 12:53PM  ETFs with exposure to Juniper Pharmaceuticals, Inc. : August 11, 2016
Aug-09-16 12:11PM  Juniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
Aug-04-16 09:53AM  Juniper Pharmaceuticals posts 2Q loss
07:07AM  Q2 2016 Juniper Pharmaceuticals Inc Earnings Release - Before Market Open
07:03AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
06:50AM  Juniper Pharmaceuticals Reports Second Quarter 2016 Financial Results PR Newswire
Jul-28-16 04:47PM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
Jul-26-16 08:00AM  Juniper Pharmaceuticals to Report Second Quarter 2016 Results on August 4, 2016 PR Newswire
Jul-20-16 07:04AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
06:50AM  Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer PR Newswire
Jul-07-16 09:00AM  Juniper Pharmaceuticals Announces Completion of Enrollment in Phase 2b Clinical Trial of COL-1077 10% Lidocaine Vaginal Gel for Gynecologic Procedure Pain PR Newswire
Jul-05-16 08:35AM  Juniper Pharmaceuticals Says Merck, Germany, Gets Japan's Regulatory Approval For OneCrinone
07:00AM  Juniper Pharmaceuticals Announces that Merck KGaA, Darmstadt, Germany, has Obtained Regulatory Approval for OneCrinone® in Japan PR Newswire
Jun-29-16 08:00AM  Juniper Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference PR Newswire
Jun-16-16 02:40PM  Juniper Pharmaceuticals Announces Phase 1 Studies of COL-1077 Lidocaine Vaginal Gel Published in Peer Reviewed Scientific Journal PR Newswire
08:25AM  Auris Medical (EARS) Jumps: Stock Adds 15.2% in Session
08:15AM  Achaogen (AKAO) Shows Strength: Stock Moves 17.8% Higher
Jun-15-16 05:18PM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements a
Jun-14-16 08:25AM  Catalyst Pharmaceuticals (CPRX) Jumps: Stock Rises 6.6%
Jun-13-16 05:45PM  Zafgen (ZFGN) Presents Favorable New Data on Beloranib
Jun-10-16 11:31AM  Ironwood/Allergan's Linzess sNDA Accepted for FDA Review
Jun-07-16 12:00PM  ARIAD (ARIA) Presents Phase II Study Data on Cancer Drug
08:40AM  NeuroDerm (NDRM) Looks Good: Stock Adds 5.1% in Session
Jun-03-16 08:15AM  Achaogen (AKAO) Shows Strength: Stock Moves 13% Higher
Jun-02-16 07:06AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
06:50AM  Juniper Pharmaceuticals Announces Planned Retirement of CEO Frank Condella PR Newswire
Jun-01-16 05:05PM  ARIAD (ARIA) Commences Phase I/II Study on Cancer Drug
08:25AM  Ariad Pharmaceuticals (ARIA) Jumps: Stock Moves Up 7.8%
May-24-16 10:15AM  Juniper Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference PR Newswire
May-23-16 08:25AM  Cardiome Pharma (CRME) Jumps: Stock Moves 8.1% Higher -5.62%
May-20-16 08:30AM  Alcobra (ADHD) Catches Eye: Stock Adds 6.3% in Session
May-18-16 01:42PM  Juniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: Q1, 2016 By the Numbers
May-17-16 08:05AM  Dermira (DERM) in Focus: Stock Gains 8.7% in Session
May-05-16 11:54AM  Juniper Pharmaceuticals Announces Publication of Phase 1 Study Demonstrating Ability of Its Proprietary Intravaginal Ring to Deliver Large Molecules PR Newswire
May-04-16 07:07AM  Q1 2016 Juniper Pharmaceuticals Inc Earnings Release - Time Not Supplied +12.50%
06:21AM  Juniper Pharmaceuticals posts 1Q profit
06:19AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
06:00AM  Juniper Pharmaceuticals Reports First Quarter 2016 Financial Results PR Newswire
Apr-26-16 08:00AM  Juniper Pharmaceuticals to Report First Quarter 2016 Results on May 4, 2016 PR Newswire
Mar-30-16 08:00AM  Juniper Pharmaceuticals Appoints Dr. Herman Weiss as Vice President, Medical Affairs and Clinical Development PR Newswire
Mar-28-16 11:30AM  Juniper's board has greater ratio of women than any other firm in Mass. at bizjournals.com
Mar-24-16 08:09AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
08:00AM  Juniper Pharmaceuticals Appoints Mary Ann Gray, Ph.D., to Board of Directors PR Newswire
Mar-21-16 08:00AM  Juniper Pharmaceuticals Affirms Development Pathway for Oxybutynin Intra-vaginal Ring for Overactive Bladder in Women PR Newswire
Mar-17-16 02:18PM  Juniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: 2015 By the Numbers
Mar-10-16 10:00AM  Juniper Pharmaceuticals posts 4Q loss -5.12%
07:07AM  Q4 2015 Juniper Pharmaceuticals Inc Earnings Release - Time Not Supplied
06:26AM  JUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
06:17AM  Juniper Pharmaceuticals Reports Fourth Quarter and Full-Year 2015 Financial Results PR Newswire
Feb-29-16 08:05AM  Juniper Pharmaceuticals to Present at ROTH Conference on March 14, 2016 PR Newswire
Feb-25-16 08:00AM  Juniper Pharmaceuticals to Report Fourth Quarter and Year End 2015 Results on March 10, 2016 PR Newswire
Jan-20-16 04:20PM  Juniper Pharmaceuticals, Inc.: Strong price momentum but will it sustain? +6.29%
08:00AM  Prominent Physicians Join Juniper Pharmaceuticals' Scientific Advisory Board PR Newswire
Jan-14-16 08:05AM  Juniper Pharmaceuticals (JNP) in Focus: Stock Jumps 7.8%
06:48AM  5 Stocks Under $10 Set to Soar at TheStreet
Jan-11-16 06:50AM  Juniper Pharmaceuticals Expands Lead Phase 2b Trial, Submits Pre-IND Meeting Request for its First Intra-vaginal Ring Product, and Adds Four Key Executives PR Newswire -9.21%
Dec-23-15 01:00PM  Juniper Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Juniper Pharmaceuticals, Inc. focuses on developing therapeutics that address unmet medical needs in women's health. The company develops its products using its drug delivery technologies, including bioadhesive delivery system, a polymer designed to adhere to epithelial surfaces or mucosa for sustained and controlled delivery of active drug product; and a novel intra-vaginal ring (IVR) technology. It offers CRINONE, a progesterone gel used for progesterone supplementation or replacement in infertile women with progesterone deficiency. The company is also developing COL-1077, a 10% lidocaine bioadhesive gel, which is in Phase 2b clinical trial for use as an acute use anesthetic for pain from minimally invasive gynecological procedures. Its products in preclinical development include JNP-0101, an oxybutynin IVR to treat overactive bladder; JNP-0201, a product candidate with natural progesterone and natural estradiol for used in hormone replacement therapy in menopausal women; and JNP-0301, a progesterone IVR used for the prevention of preterm birth. In addition, Juniper Pharmaceuticals, Inc. provides pharmaceutical development, clinical trial manufacturing, analytical, and consulting services. The company was formerly known as Columbia Laboratories, Inc. and changed its name to Juniper Pharmaceuticals, Inc. in April 2015. Juniper Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GERAGHTY JAMES ADirectorMar 17Buy4.822,0009,63765,153Mar 20 04:46 PM